Open AccessExtensive-disease small cell lung cancer, multiple relapses, five lines of therapy and more than 10-year survival
Author(s) -
Pawan Kumar Singh,
Dibas Shrestha,
Navneet Singh,
Nalini Gupta
Publication year - 2020
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr-2019-232607
Subject(s) - medicine , radiation therapy , disease , lung cancer , presentation (obstetrics) , chemotherapy , cancer , stage (stratigraphy) , rare disease , palliative care , systemic therapy , oncology , surgery , paleontology , nursing , breast cancer , biology
Small cell lung cancer (SCLC) accounts for nearly 18% of lung cancer cases. Most of the patients of SCLC are not surgical candidates, due to advanced stage at presentation hence only viable options are chemotherapy and radiotherapy. Long-term survival in SCLC is extremely rare due to relapses and comorbidities. Ten-year survival has never been reported in cases with extensive disease at presentation and history of relapses. Here we are describing a case of extensive disease SCLC who has survived multiple relapses and has received five lines of systemic therapy apart from radiation and palliative care. This case emphasises on the need of active and strict disease surveillance at each follow-up.